Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo bounces back: stock up 19.2% in first quarter -- Index.

This article was originally published in The Tan Sheet

Executive Summary

PERRIGO STOCK RECOVERS FROM YEAR-END HIT WITH 19.2% FIRST QUARTER GROWTH after closing 1996 with a 23.2% drop. Investors may be reacting to the OTC private labeler's earnings upturn after several years of declines. In mid-February, Perrigo reported second quarter sales ahead 10% on earnings growth of 12.6%. A severe cough, cold and flu season drove Perrigo's largest OTC segments -- cough/cold remedies and analgesics

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel